Corporacion America Airports reported Q2 2026 revenue of $534 million, surpassing analyst estimates of $497.52 million, showing strong sales performance. However, earnings per share (EPS) came in at $0.32, below the expected $0.51, indicating lower profitability per share. The company maintains a healthy financial position with a P/E ratio of 12.94, a debt-to-equity ratio of 0.61, and a current ratio of 1.40. These results suggest solid operational growth despite the earnings miss, providing mixed signals for investors assessing future prospects.
Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...
Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...
AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...
President Trump signed a proclamation on October 23, 2026, reshuffling which Canadian goods face his 50% tariffs, removing items like plywood and packing crates but adding others such as carpets and vinyl flooring. The broad tariffs on about $20 bill...
Injective CEO Eric Chen met with officials from the White House, SEC, and CFTC in October 2026 to discuss advancing regulated onchain finance and tokenization of real-world assets (RWAs) in the US. Injective, registered as a transfer agent by the SEC...
